Skip to content

The effect of lidocaine and prilocaine for for inferior alveolar nerve block in mandibular impacted and partially impacted third molar surgery.

Comparison of hemodynamic changes following lidocaine 2% versus prilocaine 3% administration for inferior alveolar nerve block in mandibular impacted and partially impacted third molar surgery: A double blind clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130812014333N243
Enrollment
62
Registered
2025-03-10
Start date
2025-03-10
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impacted tooth. Impacted teeth

Interventions

Intervention 1: In the first intervention group, they will receive 2% lidocaine with epinephrine 1:100,000 from Darupakhsh Company, then two 1.8 ml carpools will be injected for inferior alveolar and

Sponsors

Islamic Azad University, Khorasgan Branch
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Informed consent Age between 20 and 50 years Patients whose mandibular third molar is impacted or partially impacted

Exclusion criteria

Exclusion criteria: History of anticoagulant medications History of systemic disease, including cardiovascular disease, hypertension, diabetes, asthma, bronchospasm, or angioedema Nasal polyps Moderate to severe renal failure Liver failure Pregnant women

Design outcomes

Primary

MeasureTime frame
Systolic Blood Pressure. Timepoint: Before injection, immediately, and 15 minutes after injection. Method of measurement: Using a blood pressure monitor.;Diastolic blood pressure. Timepoint: Before injection, immediately, and 15 minutes after injection. Method of measurement: Using a blood pressure monitor.;Oxygen saturation percentage. Timepoint: Before injection, immediately, and 15 minutes after injection. Method of measurement: Using a blood pressure monitor.;Heart rate. Timepoint: Before injection, immediately, and 15 minutes after injection. Method of measurement: Using a pulse oximeter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Adibi

Islamic Azad University, Khorasgan Branch

m.adibi@gmail.com+98 31 3535 4003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026